{"id": "F3.2-000162-P1", "question": "Which drugs target both HDAC8 and HDAC9?", "gold_cypher": "MATCH (t:Therapy)-[r1:TARGETS]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('HDAC8')\n   OR any(s IN coalesce(g1.synonyms, []) WHERE toLower(s) = toLower('HDAC8'))\nMATCH (t)-[r2:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('HDAC9')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('HDAC9'))\nRETURN\n  g1.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r1.moa AS targets_moa,\n  coalesce(r1.ref_sources, []) AS ref_sources,\n  coalesce(r1.ref_ids, []) AS ref_ids,\n  coalesce(r1.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[r1:TARGETS]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('HDAC8') OR any(s IN coalesce(g1.synonyms, []) WHERE toLower(s) = toLower('HDAC8'))\nMATCH (t)-[r2:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('HDAC9') OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('HDAC9'))\nRETURN\n  t.name AS therapy_name,\n  g1.symbol AS gene1_symbol,\n  g2.symbol AS gene2_symbol,\n  r1.moa AS targets_moa,\n  coalesce(r1.ref_sources, []) AS ref_sources,\n  coalesce(r1.ref_ids, []) AS ref_ids,\n  coalesce(r1.ref_urls, []) AS ref_urls\nLIMIT 100", "gold_rows": [{"gene_symbol": "HDAC8", "therapy_name": "Abexinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed"], "ref_ids": ["16731764", "20145726", "25520806"], "ref_urls": ["http://europepmc.org/abstract/MED/16731764", "http://europepmc.org/abstract/MED/20145726", "http://europepmc.org/abstract/MED/25520806"]}, {"gene_symbol": "HDAC8", "therapy_name": "Belinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/206256lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206256lbl.pdf"]}, {"gene_symbol": "HDAC8", "therapy_name": "Panobinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2015/205353s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf"]}], "generated_rows": [{"therapy_name": "Abexinostat", "gene1_symbol": "HDAC8", "gene2_symbol": "HDAC9", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed"], "ref_ids": ["16731764", "20145726", "25520806"], "ref_urls": ["http://europepmc.org/abstract/MED/16731764", "http://europepmc.org/abstract/MED/20145726", "http://europepmc.org/abstract/MED/25520806"]}, {"therapy_name": "Belinostat", "gene1_symbol": "HDAC8", "gene2_symbol": "HDAC9", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/206256lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206256lbl.pdf"]}, {"therapy_name": "Panobinostat", "gene1_symbol": "HDAC8", "gene2_symbol": "HDAC9", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2015/205353s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf"]}], "error": null}
{"id": "F4.2-000016-P2", "question": "Which drugs target biomarkers of resistance to Platinum Compound in Ovarian Serous Carcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Platinum Compound')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Platinum Compound'))\n  OR toLower(t1.name) CONTAINS toLower('Platinum Compound')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'ovarian' AND\n    toLower(rel.disease_name) CONTAINS 'serous' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Platinum Compound')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('carboplatin') OR\n  toLower(t.name) = toLower('cisplatin') OR\n  toLower(t.name) = toLower('oxaliplatin') OR\n  any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('carboplatin')) OR\n  any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('cisplatin')) OR\n  any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('oxaliplatin')) OR\n  toLower(t.name) CONTAINS toLower('carboplatin') OR\n  toLower(t.name) CONTAINS toLower('cisplatin') OR\n  toLower(t.name) CONTAINS toLower('oxaliplatin') OR\n  any(tag IN coalesce(t.tags, []) WHERE toLower(tag) CONTAINS toLower('platinum'))\n)\nAND toLower(rel.effect) = 'resistance'\nAND toLower(rel.disease_name) CONTAINS toLower('ovarian')\nAND toLower(rel.disease_name) CONTAINS toLower('serous')\nAND toLower(rel.disease_name) CONTAINS toLower('carcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"gene_symbol": "AURKA", "therapy_name": "Alisertib", "targets_moa": "Serine/threonine-protein kinase Aurora-A inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["22016509"], "ref_urls": ["http://europepmc.org/abstract/MED/22016509"]}, {"gene_symbol": "AURKA", "therapy_name": "Tozasertib", "targets_moa": "Serine/threonine-protein kinase Aurora inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["14981513", "26345296"], "ref_urls": ["http://europepmc.org/abstract/MED/14981513", "http://europepmc.org/abstract/MED/26345296"]}], "generated_rows": [], "error": null}
{"id": "F4.2-000184-P3", "question": "Find therapies that target resistance genes for Imatinib in Melanoma.", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Imatinib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Imatinib'))\n  OR toLower(t1.name) CONTAINS toLower('Imatinib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Imatinib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)\nWHERE toLower(t.name) = toLower('Imatinib') OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Imatinib'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.effect) = toLower('resistance')\n  AND toLower(rel.disease_name) CONTAINS toLower('melanoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL OR variant_name IS NOT NULL\nUNWIND pmids AS p\nWITH\n  variant_name,\n  gene_symbol,\n  therapy_name,\n  effect,\n  disease_name,\n  collect(DISTINCT p) AS pmids\nRETURN\n  variant_name,\n  gene_symbol,\n  therapy_name,\n  effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dasatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}, {"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dasatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}, {"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dasatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Amuvatinib", "targets_moa": "Platelet-derived growth factor receptor alpha inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Avapritinib", "targets_moa": "Platelet-derived growth factor receptor alpha inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "C-Met Inhibitor", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Cediranib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Crenolanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://arogpharma.com/crenolanib", "22745105", "24623852"], "ref_urls": ["http://arogpharma.com/crenolanib", "http://europepmc.org/abstract/MED/22745105", "http://europepmc.org/abstract/MED/24623852"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Dovitinib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Foretinib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Linifanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["16648571", "17343372"], "ref_urls": ["http://europepmc.org/abstract/MED/16648571", "http://europepmc.org/abstract/MED/17343372"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Midostaurin", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Motesanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Nintedanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/205832s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Pazopanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Quizartinib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Regorafenib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Ripretinib", "targets_moa": "Platelet-derived growth factor receptor alpha inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Sunitinib", "targets_moa": "Platelet-derived growth factor receptor alpha inhibitor | Platelet-derived growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "TRK Inhibitor", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Vatalanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}], "generated_rows": [{"variant_name": "KIT Amplification", "gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Mucosal Melanoma", "pmids": ["23775962"]}, {"variant_name": "KIT D820Y", "gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["21642685"]}, {"variant_name": "KIT L576P", "gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["19671763"]}, {"variant_name": "PDGFRA V658A", "gene_symbol": "PDGFRA", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24132921"]}], "error": null}
{"id": "F4.2-000171-S1-P2", "question": "Which drugs target biomarkers of resistance to Dasatinib in Naevocarcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Dasatinib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Dasatinib'))\n  OR toLower(t1.name) CONTAINS toLower('Dasatinib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Dasatinib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Dasatinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Dasatinib'))\n  OR toLower(t.name) CONTAINS toLower('Dasatinib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND toLower(rel.disease_name) CONTAINS toLower('naevo')\nAND toLower(rel.disease_name) CONTAINS toLower('carcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"gene_symbol": "BRAF", "therapy_name": "Agerafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"], "ref_urls": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "BRAF Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Belvarafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"], "ref_urls": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"]}, {"gene_symbol": "BRAF", "therapy_name": "Dabrafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"]}, {"gene_symbol": "BRAF", "therapy_name": "Encorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Pan-RAF Inhibitor LY3009120", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["25965804"], "ref_urls": ["http://europepmc.org/abstract/MED/25965804"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "TRK Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Tovorafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other", "PubMed"], "ref_ids": ["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php", "5653214"], "ref_urls": ["http://europepmc.org/abstract/MED/5653214", "http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php"]}, {"gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/202429s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202429s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}], "generated_rows": [], "error": null}
{"id": "F4.2-000042-P3", "question": "Find therapies that target resistance genes for Gemcitabine in Pancreatic Adenocarcinoma.", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Gemcitabine')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Gemcitabine'))\n  OR toLower(t1.name) CONTAINS toLower('Gemcitabine')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'pancreatic' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Gemcitabine')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (toLower(t.name) = toLower('Gemcitabine') OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Gemcitabine')))\nAND toLower(rel.effect) = 'resistance'\nAND toLower(rel.disease_name) CONTAINS toLower('pancreatic')\nAND toLower(rel.disease_name) CONTAINS toLower('adenocarcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"gene_symbol": "KRAS", "therapy_name": "Adagrasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["31658955"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/31658955/"]}, {"gene_symbol": "KRAS", "therapy_name": "Salirasib", "targets_moa": "RAS inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["22547163"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/22547163/"]}, {"gene_symbol": "KRAS", "therapy_name": "Sotorasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["31189530", "31666701", "31820981", "32568546"], "ref_urls": ["http://europepmc.org/abstract/MED/31189530", "http://europepmc.org/abstract/MED/31666701", "http://europepmc.org/abstract/MED/31820981", "http://europepmc.org/abstract/MED/32568546"]}], "generated_rows": [{"variant_name": "KRAS G12/G13", "gene_symbol": "KRAS", "therapy_name": "Gemcitabine", "effect": "resistance", "disease_name": "Pancreatic Adenocarcinoma", "pmids": ["24915778"]}, {"variant_name": "RB1 Overexpression", "gene_symbol": "RB1", "therapy_name": "Gemcitabine", "effect": "resistance", "disease_name": "Pancreatic Adenocarcinoma", "pmids": ["11792751"]}], "error": null}
{"id": "F4.1-000033-S1-P3", "question": "Show treatments hitting ALK that have biomarker evidence in Non-small Cell Lung Carcinoma.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK') OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.effect) = 'sensitivity' OR toLower(rel.effect) = 'resistance'\nAND toLower(rel.disease_name) CONTAINS toLower('lung')\nAND toLower(rel.disease_name) CONTAINS toLower('non-small')\nAND toLower(rel.disease_name) CONTAINS toLower('cell')\nAND toLower(rel.disease_name) CONTAINS toLower('carcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(gene:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE gene.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "ALK I1171", "gene_symbol": "ALK", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534", "25736571"]}, {"variant_name": "ALK I1171N AND HIP1::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK I1171S", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21575866"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK T1151dup", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}, {"variant_name": "EGFR C797S", "gene_symbol": "EGFR", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28287083"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28287083"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "ROS1 G2032R AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Brigatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26372962"]}, {"variant_name": "ALK G1269A AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ALK I1171", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534", "25736571", "24675041"]}, {"variant_name": "ALK Mutation", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24670165"]}, {"variant_name": "ALK S1206Y AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24670165"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK F1245C", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26775591"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202R", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202del", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27432227"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "EML4 EML4::ALK e6::e20", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ROS1 G2032R AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26372962"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}, {"variant_name": "ALK F1174C", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ALK F1174L", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21030459"]}, {"variant_name": "ALK F1174V", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24736079"]}, {"variant_name": "ALK G1202R AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23729361"]}, {"variant_name": "ALK G1269A AND EML4::ALK e6::e19 AND ALK Amplification", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "ALK G1269A AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23434628"]}, {"variant_name": "ALK I1171", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393798", "24675041", "25228534"]}, {"variant_name": "ALK I1171N AND HIP1::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "ALK L1152P", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ALK L1198F", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "ALK L1198P", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21948233"]}, {"variant_name": "AREG Expression", "gene_symbol": "AREG", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23344087", "21791641"]}, {"variant_name": "EGFR L858R", "gene_symbol": "EGFR", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "EML4 EML4::ALK Fusion", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["20979469", "21258415", "22912387"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK Amplification", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099", "23344087", "22277784"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910", "23434628", "24675041", "22235099"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK F1245C", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26775591"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202R", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1269A", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099", "23344087", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK I1171S", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1152R", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21791641"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099", "23344087", "22277784", "21948233"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1198F AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK S1206Y", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK T1151dup", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "EML4 EML4::ALK e20::e20", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["20979469", "22912387"]}, {"variant_name": "EML4 EML4::ALK e2::e20", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["18927303"]}, {"variant_name": "EML4 EML4::ALK e6::e20", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["20979469", "22912387"]}, {"variant_name": "KIF5B KIF5B::MET Fusion", "gene_symbol": "KIF5B", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29102694"]}, {"variant_name": "KRAS Amplification", "gene_symbol": "KRAS", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30072474"]}, {"variant_name": "KRAS G12C", "gene_symbol": "KRAS", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "KRAS G12V", "gene_symbol": "KRAS", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "MDM2 Amplification AND MET D1010H", "gene_symbol": "MDM2", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25898965"]}, {"variant_name": "MET Amplification", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31584608", "21623265", "27664533", "21716144"]}, {"variant_name": "MET Amplification AND MET Splice Site (c.3028G>A)", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26729443"]}, {"variant_name": "MET D1010N", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26892698"]}, {"variant_name": "MET D1228N", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27343442"]}, {"variant_name": "MET Exon 14 Mutation", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31932802", "31416808"]}, {"variant_name": "MET Exon 14 Skipping Mutation", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["35679833", "31584608", "123413", "26892698"]}, {"variant_name": "MET Exon 14 Skipping Mutation AND MET D1228N", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31055074"]}, {"variant_name": "MET MET::ATXN7L1 Fusion", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30339198"]}, {"variant_name": "NOT MET Amplification AND MET Exon 14 Skipping Mutation", "gene_symbol": "NOT", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27693535"]}, {"variant_name": "ROS1 G2032R", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29333528", "25688157", "27401242"]}, {"variant_name": "ROS1 G2032R AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157", "26372962"]}, {"variant_name": "ROS1 G2101A AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157"]}, {"variant_name": "ROS1 L2026M AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157"]}, {"variant_name": "ROS1 L2155S AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157"]}, {"variant_name": "ROS1 S1986F", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29333528", "27401242"]}, {"variant_name": "ROS1 S1986Y", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27401242"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}, {"variant_name": "ALK G1269A AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Ensartinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31628085"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Ensartinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31628085"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Ensartinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31628085"]}, {"variant_name": "EML4 EML4::NTRK3 Fusion", "gene_symbol": "EML4", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["34625502"]}, {"variant_name": "NTRK3 G623R AND EML4::NTRK3 Fusion", "gene_symbol": "NTRK3", "therapy_name": "Entrectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["34625502"]}, {"variant_name": "SQSTM1 SQSTM1::NTRK1 Fusion", "gene_symbol": "SQSTM1", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28183697"]}, {"variant_name": "ALK Mutation", "gene_symbol": "ALK", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30413378"]}, {"variant_name": "EML4 EML4::ALK Fusion", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26554404"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202R AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29650534"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1198F AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "ROS1 G2032R AND v::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25733882"]}, {"variant_name": "ROS1 L2026M AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25733882"]}, {"variant_name": "ROS1 S1986Y/F", "gene_symbol": "ROS1", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27401242"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Lorlatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}], "generated_rows": [{"variant_name": "ALK Alternative Transcript (ATI)", "gene_symbol": "ALK", "therapy_name": "ALK Inhibitor ASP3026", "effect": "sensitivity", "disease_name": "Melanoma", "pmids": ["29054983"]}, {"variant_name": "ALK Alternative Transcript (ATI)", "gene_symbol": "ALK", "therapy_name": "Alectinib", "effect": "sensitivity", "disease_name": "Melanoma", "pmids": ["29054983"]}, {"variant_name": "ALK F1174L", "gene_symbol": "ALK", "therapy_name": "Alectinib", "effect": "sensitivity", "disease_name": "Neuroblastoma", "pmids": ["21575866"]}, {"variant_name": "ALK I1171", "gene_symbol": "ALK", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534", "25736571"]}, {"variant_name": "ALK I1171N AND HIP1::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "EML4 EML4::ALK Fusion", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "sensitivity", "disease_name": "Malignant Pleural Mesothelioma", "pmids": ["32600123"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK I1171S", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["29650534"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21575866"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK T1151dup", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "FUS FUS::TFCP2 Fusion AND ALK Exon 2-18 Deletion", "gene_symbol": "FUS", "therapy_name": "Alectinib", "effect": "sensitivity", "disease_name": "Spindle Cell Rhabdomyosarcoma", "pmids": ["39302072"]}, {"variant_name": "KANK4 KANK4::ALK Fusion", "gene_symbol": "KANK4", "therapy_name": "Alectinib", "effect": "sensitivity", "disease_name": "Pancreatic Acinar Cell Adenocarcinoma", "pmids": ["35005993"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}, {"variant_name": "ALK Exon 4-11 Deletion", "gene_symbol": "ALK", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Neuroblastoma", "pmids": ["27049722"]}, {"variant_name": "ALK G1269A AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["25727400"]}, {"variant_name": "EGFR C797S", "gene_symbol": "EGFR", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28287083"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28287083"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["29650534"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "ROS1 G2032R AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Brigatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26372962"]}, {"variant_name": "ALK Alternative Transcript (ATI)", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Melanoma", "pmids": ["29054983"]}, {"variant_name": "ALK G1269A AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ALK G1269A AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["25727400"]}, {"variant_name": "ALK I1171", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534", "25736571", "24675041"]}, {"variant_name": "ALK I1171T", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Neuroblastoma", "pmids": ["29907598"]}, {"variant_name": "ALK Mutation", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24670165"]}, {"variant_name": "ALK S1206Y AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24670165"]}, {"variant_name": "CD72 CD72::ROS1 Fusion", "gene_symbol": "CD72", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["26917690"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK F1245C", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26775591"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202R", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202del", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27432227"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["29650534"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK S1206Y", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "EML4 EML4::ALK e6::e20", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ROS1 G2032R AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26372962"]}, {"variant_name": "STRN STRN::ALK Fusion", "gene_symbol": "STRN", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Colon Adenocarcinoma", "pmids": ["26933125"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}, {"variant_name": "ALK Alternative Transcript (ATI)", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Skin Melanoma", "pmids": ["26444240"]}, {"variant_name": "ALK Alternative Transcript (ATI)", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["26444240"]}, {"variant_name": "ALK Alternative Transcript (ATI)", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Melanoma", "pmids": ["29054983"]}, {"variant_name": "ALK Expression", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26498130"]}, {"variant_name": "ALK F1174C", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ALK F1174L", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Neuroblastoma", "pmids": ["23598171", "21948233"]}, {"variant_name": "ALK F1174L", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21030459"]}, {"variant_name": "ALK F1174V", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24736079"]}, {"variant_name": "ALK G1202R AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23729361"]}, {"variant_name": "ALK G1269A AND EML4::ALK e6::e19 AND ALK Amplification", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "ALK G1269A AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23434628"]}, {"variant_name": "ALK I1171", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393798", "24675041", "25228534"]}, {"variant_name": "ALK I1171N AND HIP1::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "ALK L1152P", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ALK L1198F", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "ALK L1198P", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21948233"]}, {"variant_name": "ALK R1275Q", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Neuroblastoma", "pmids": ["21838707", "23598171", "22072639"]}, {"variant_name": "ALK R214H", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Nasal Type Extranodal NK/T-cell Lymphoma", "pmids": ["27594191"]}, {"variant_name": "AREG Expression", "gene_symbol": "AREG", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23344087", "21791641"]}, {"variant_name": "BRAF D594N AND BRAF G466A", "gene_symbol": "BRAF", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Collecting Duct Carcinoma", "pmids": ["28783719"]}, {"variant_name": "CLTC CLTC::ALK Fusion", "gene_symbol": "CLTC", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["26221234"]}, {"variant_name": "DCTN1 DCTN1::ALK Fusion", "gene_symbol": "DCTN1", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Inflammatory Myofibroblastic Tumor", "pmids": ["26062823"]}, {"variant_name": "EGFR Exon 19 Deletion AND MET Exon 14 Skipping Mutation", "gene_symbol": "EGFR", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["30341016"]}, {"variant_name": "EGFR G719A AND MET Splice Site (c.2888-21_2888-20delinsGC)", "gene_symbol": "EGFR", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["30922580"]}, {"variant_name": "EGFR L858R", "gene_symbol": "EGFR", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "EML4 EML4::ALK Fusion", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["20979473"]}, {"variant_name": "EML4 EML4::ALK Fusion", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["20979469", "21258415", "22912387"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK Amplification", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099", "23344087", "22277784"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910", "23434628", "24675041", "22235099"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK F1245C", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26775591"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202R", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1269A", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099", "23344087", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK I1171S", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1152R", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21791641"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099", "23344087", "22277784", "21948233"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1198F", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["26698910"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1198F AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1198F AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["26698910"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK S1206Y", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK T1151dup", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "EML4 EML4::ALK e20::e20", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["20979469", "22912387"]}, {"variant_name": "EML4 EML4::ALK e2::e20", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["18927303"]}, {"variant_name": "EML4 EML4::ALK e6::e20", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["20979469", "22912387"]}, {"variant_name": "EML4 EML4::ALK e6::e20", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["25408655"]}, {"variant_name": "EML6 EML6::ALK Fusion AND FBXO11::ALK Fusion", "gene_symbol": "EML6", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["30368418"]}, {"variant_name": "ERC1 ERC1::ALK Fusion", "gene_symbol": "ERC1", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Sarcoma", "pmids": ["34464935"]}, {"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": "ETV6", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Mammary Analogue Secretory Carcinoma", "pmids": ["26884591"]}, {"variant_name": "EWSR1 EWSR1::ATF1 Fusion", "gene_symbol": "EWSR1", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Clear Cell Sarcoma", "pmids": ["29741569"]}, {"variant_name": "IGF1R Overexpression", "gene_symbol": "IGF1R", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Salivary Gland Adenoid Cystic Carcinoma", "pmids": ["28954282"]}, {"variant_name": "KIF5B KIF5B::MET Fusion", "gene_symbol": "KIF5B", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29102694"]}, {"variant_name": "KRAS Amplification", "gene_symbol": "KRAS", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30072474"]}, {"variant_name": "KRAS G12C", "gene_symbol": "KRAS", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "KRAS G12V", "gene_symbol": "KRAS", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "LMNA LMNA::NTRK1 Fusion", "gene_symbol": "LMNA", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Congenital Fibrosarcoma", "pmids": ["30709876"]}, {"variant_name": "MDM2 Amplification AND MET D1010H", "gene_symbol": "MDM2", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25898965"]}, {"variant_name": "MET Amplification", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31584608", "21623265", "27664533", "21716144"]}, {"variant_name": "MET Amplification", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Gastrointestinal System Cancer", "pmids": ["22042947"]}, {"variant_name": "MET Amplification", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["27325282", "23729478"]}], "error": null}
